ODRONEXTAMAB
UNII 8R5CM46UIO

Substance Identification & Data

This profile provides standardized clinical and technical data for Odronextamab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 8R5CM46UIO.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1801338-64-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

8R5CM46UIO

CAS Registry Number

1801338-64-6

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ODRONEXTAMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C119615

National Cancer Institute reference terminology for clinical and research data.

INN ID

11035

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

EF-150

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Odronextamab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ODRONEXTAMAB

Common Names & Synonyms

ANTI-CD20 X ANTI-CD3 BISPECIFIC MONOCLONAL ANTIBODY REGN1979

ANTI-CD20/CD3 MONOCLONAL ANTIBODY REGN1979

IMMUNOGLOBULIN G4, ANTI-(HUMAN CD20 ANTIGEN) (HUMAN REGN1979 .GAMMA.-CHAIN), DISULFIDE WITH HUMAN REGN1979 .KAPPA.-CHAIN, DIMER WITH IMMUNOGLOBULIN G4, ANTI-(HUMAN CD3 ANTIGEN) (HUMAN REGN1979 .GAMMA.-CHAIN), DISULFIDE WITH HUMAN REGN1979 .KAPPA.-CHAIN

MAB HUMAN (IGG4) ANTI P11836 (CD20_HUMAN) & ANTI P07766 (CD3E_HUMAN) (REGN1979)

ODRONEXTAMAB [INN]

ODRONEXTAMAB [USAN]

ODRONEXTAMAB [WHO-DD]